Abstract
Saxitoxin (STX) and tetrodotoxin (TTX) are frequently used to selectively block sodium channels. In this study, we provide evidence that commercial STX also inhibits L-type Ca2+ currents (ICa,L) in adult mouse ventricular myocytes (VMs) and tsA-201 cells that were transiently cotransfected with three calcium channel subunits. We measured inhibition of sodium currents (INa) in mouse VMs, of ICa,L in mouse VM and tsA-201 cells, and intracellular calcium concentration ([Ca2+]i) transients in single mouse VMs. STX or TTX was abruptly applied before the test voltage pulse using a rapid solution switcher device. STX (10 μM; Calbiochem) and TTX (60 μM; Sigma-Aldrich) completely blocked INa in mouse VMs. However, STX at 10 μM also reduced ICa,L in mouse VM by 39% (P < 0.0001; n = 14), whereas TTX at 60 μM had no effect on ICa,L. STX (10 μM; Calbiochem) reduced the amplitude of the [Ca2+]i transients in mouse VMs by 36% (P < 0.0001; n = 10). In contrast, TTX (60 μM; Sigma-Aldrich) only reduced the amplitude of the [Ca2+]i transients by 9% (P = 0.003; n = 5). STX (10 μM) obtained from Sigma-Aldrich showed a similar inhibitory effect on ICa,L (33%) (P < 0.0001; n = 5) in mouse VMs. STX (Calbiochem) inhibited the calcium currents of tsA-201 cells in a dose-dependent manner. This inhibition was voltage-independent. The current-voltage relationship of calcium currents in tsA-201 cells was not altered by STX. These results indicate that STX partially blocks L-type Ca2+ channels and thus provide further evidence that its effects are not specific for Na+ channels.
Footnotes
-
This work was supported in part by National Institutes of Health Grants HL44630 and HL52338.
-
DOI: 10.1124/jpet.103.056564.
-
ABBREVIATIONS: STX, saxitoxin; TTX, tetrodotoxin; [Ca2+]i, intracellular calcium concentration; VM, ventricular myocyte; ICP, inductively coupled plasma; I-V, current-voltage relationship.
-
↵1 Current address: Abbott Laboratories, Chicago, IL 60064.
- Received July 3, 2003.
- Accepted October 9, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|